0001209191-20-033605.txt : 20200602 0001209191-20-033605.hdr.sgml : 20200602 20200602170051 ACCESSION NUMBER: 0001209191-20-033605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200601 FILED AS OF DATE: 20200602 DATE AS OF CHANGE: 20200602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GANNON STEVEN CENTRAL INDEX KEY: 0001643085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36687 FILM NUMBER: 20937898 MAIL ADDRESS: STREET 1: C/O XENON PHARMACEUTICALS INC. STREET 2: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A0 ZIP: V5G 4W8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001582313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980661854 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W BUSINESS PHONE: (604) 484-3300 MAIL ADDRESS: STREET 1: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A1 ZIP: V5G 48W 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-01 0 0001582313 Xenon Pharmaceuticals Inc. XENE 0001643085 GANNON STEVEN 200 - 3650 GILMORE WAY BURNABY A1 V5G 4M1 BRITISH COLUMBIA, CANADA 1 0 0 0 Stock Option (Right to Buy) 13.11 2020-06-01 4 A 0 10000 0.00 A 2030-05-31 Common Shares 10000 10000 D One-third of the total shares subject to the Option shall vest on the one year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the two year anniversary of the grant date, one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. /s/ Cassandra Robinson, Attorney-in-fact 2020-06-02